---
title: "Lasso-Cox Regression for Variable Selection in Survival Analysis"
author: "ClinicoPath Package"
date: "`r Sys.Date()`"
output: html_document
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(
  collapse = TRUE,
  comment = "#>",
  fig.width = 8,
  fig.height = 6,
  dpi = 300,
    echo = TRUE,
  eval = FALSE
)

# Load required packages
suppressPackageStartupMessages({
  library(jmvcore)
  library(survival)
  library(glmnet)
  if (requireNamespace("ClinicoPath", quietly = TRUE)) {
    library(ClinicoPath)
  }
})
```

# Introduction to Lasso-Cox Regression

## What is Lasso-Cox Regression?

Lasso-Cox regression combines the Cox proportional hazards model with **L1 regularization** (Lasso penalty) to perform automatic variable selection in survival analysis. This technique is particularly valuable when:

- You have many potential predictors (high-dimensional data)
- The number of variables approaches or exceeds the sample size
- You want to identify the most important prognostic factors
- You need to prevent overfitting in survival models

### Key Advantages

1. **Automatic Variable Selection**: Shrinks coefficients of less important variables to exactly zero
2. **Handles High-Dimensional Data**: Works even when p ≥ n (more variables than observations)
3. **Prevents Overfitting**: Regularization improves model generalizability
4. **Clinical Interpretability**: Produces sparse models with selected key variables
5. **Cross-Validation**: Optimal tuning parameter selection through CV

## When to Use Lasso-Cox Regression

### Ideal Scenarios

- **Genomic/Biomarker Studies**: Gene expression, proteomics, metabolomics data
- **Large Clinical Datasets**: Many potential prognostic factors to screen
- **Predictive Modeling**: Building parsimonious prognostic models
- **Exploratory Analysis**: Identifying key variables from large candidate sets

### Prerequisites

- **Survival Outcome**: Time-to-event data with censoring
- **Multiple Predictors**: At least 2 variables (typically many more)
- **Adequate Events**: At least 5-10 events for reliable estimation
- **No Perfect Separation**: Variables shouldn't perfectly predict outcomes

# Statistical Background

## The Lasso-Cox Model

The Lasso-Cox regression minimizes the penalized partial log-likelihood:

$$\ell(\beta) - \lambda \sum_{j=1}^p |\beta_j|$$

Where:
- $\ell(\beta)$ is the Cox partial log-likelihood
- $\lambda$ is the regularization parameter (tuning parameter)
- $\sum_{j=1}^p |\beta_j|$ is the L1 penalty (Lasso)

### Key Parameters

1. **Lambda (λ)**: Controls the strength of regularization
   - **lambda.min**: Minimizes cross-validation error
   - **lambda.1se**: Uses 1-standard-error rule (more parsimonious)

2. **Cross-Validation**: Selects optimal λ through k-fold CV
   - Typically 5-10 folds
   - Balances model fit vs. complexity

## Performance Metrics

### Concordance Index (C-index)
- Measures discriminative ability
- Range: 0.5 (random) to 1.0 (perfect)
- Interpretation:
  - < 0.6: Poor discrimination
  - 0.6-0.7: Fair discrimination
  - 0.7-0.8: Good discrimination
  - > 0.8: Excellent discrimination

### Risk Stratification
- **Log-rank Test**: Tests survival differences between risk groups
- **Hazard Ratio**: Compares high vs. low risk groups
- **Survival Curves**: Visual assessment of risk group separation

# Clinical Examples

## Example 1: Lung Cancer Prognostic Model

We'll analyze a lung cancer dataset to identify key prognostic factors from clinical variables.

```{r lung-cancer-example}
# Load example data (would be provided in package)
# For this example, we'll simulate realistic lung cancer data
set.seed(123)
n <- 180
lung_data <- data.frame(
  # Survival outcome
  follow_up_months = round(rexp(n, rate = 0.05) + runif(n, 0, 12), 1),
  progression = factor(rbinom(n, 1, 0.6), levels = c(0, 1), labels = c("No", "Yes")),
  
  # Clinical variables
  age = round(rnorm(n, 65, 10)),
  gender = factor(sample(c("Male", "Female"), n, replace = TRUE, prob = c(0.6, 0.4))),
  stage = factor(sample(c("I", "II", "III", "IV"), n, replace = TRUE, 
                        prob = c(0.2, 0.3, 0.3, 0.2))),
  histology = factor(sample(c("Adenocarcinoma", "Squamous", "Other"), n, replace = TRUE,
                            prob = c(0.5, 0.3, 0.2))),
  smoking_status = factor(sample(c("Never", "Former", "Current"), n, replace = TRUE,
                                 prob = c(0.2, 0.5, 0.3))),
  tumor_size_cm = round(rnorm(n, 4.5, 2.0), 1),
  ecog_ps = factor(sample(0:2, n, replace = TRUE, prob = c(0.4, 0.4, 0.2))),
  
  # Laboratory values
  hemoglobin = round(rnorm(n, 12.5, 2.0), 1),
  wbc_count = round(rnorm(n, 8.5, 3.0), 1),
  creatinine = round(rnorm(n, 1.1, 0.3), 2)
)

# Display basic characteristics
str(lung_data)
```

### Running Lasso-Cox Analysis

```{r lung-cancer-analysis, eval=FALSE}
# In jamovi, you would select:
# Analyses → ClinicoPath Survival → Lasso-Cox Regression

# Programmatically (if running in R):
lung_result <- lassocox(
  data = lung_data,
  elapsedtime = "follow_up_months",
  outcome = "progression",
  outcomeLevel = "Yes",
  explanatory = c("age", "gender", "stage", "histology", "smoking_status", 
                  "tumor_size_cm", "ecog_ps", "hemoglobin", "wbc_count", "creatinine"),
  lambda = "lambda.1se",  # Use 1-SE rule for more parsimonious model
  nfolds = 10,            # 10-fold cross-validation
  standardize = TRUE      # Standardize variables
)
```

### Expected Results Interpretation

1. **Model Summary**:
   - Total variables: 10
   - Selected variables: 3-5 (with lambda.1se)
   - Selection proportion: 30-50%

2. **Selected Variables** (typical results):
   - `stage`: Strong prognostic factor (HR > 1)
   - `ecog_ps`: Performance status effect
   - `age`: Age-related risk
   - `tumor_size_cm`: Tumor burden effect

3. **Performance Metrics**:
   - C-index: 0.65-0.75 (fair to good discrimination)
   - Log-rank p-value: < 0.05 (significant stratification)
   - Hazard ratio: 2.0-3.0 (moderate to strong risk stratification)

## Example 2: High-Dimensional Genomic Study

This example demonstrates Lasso-Cox with high-dimensional genomic data where p >> n.

```{r genomic-example}
# Simulate high-dimensional genomic data
set.seed(456)
n_patients <- 100
n_genes <- 500

# Create genomic dataset
genomic_data <- data.frame(
  # Survival outcome
  survival_months = round(rweibull(n_patients, shape = 1.5, scale = 24), 1),
  death = factor(rbinom(n_patients, 1, 0.4), levels = c(0, 1), labels = c("No", "Yes")),
  
  # Clinical variables
  age = round(rnorm(n_patients, 60, 12)),
  stage = factor(sample(1:3, n_patients, replace = TRUE, prob = c(0.4, 0.4, 0.2)),
                 levels = 1:3, labels = c("Early", "Intermediate", "Advanced"))
)

# Add gene expression data (standardized)
gene_matrix <- matrix(rnorm(n_patients * n_genes), nrow = n_patients, ncol = n_genes)
colnames(gene_matrix) <- paste0("GENE_", sprintf("%03d", 1:n_genes))

# Combine clinical and genomic data
genomic_data <- cbind(genomic_data, gene_matrix)

cat("Dataset dimensions:", nrow(genomic_data), "patients ×", ncol(genomic_data), "variables")
cat("\nNumber of genes:", n_genes)
cat("\nEvents:", sum(genomic_data$death == "Yes"), "deaths")
```

### High-Dimensional Analysis Setup

```{r genomic-analysis-setup, eval=FALSE}
# For high-dimensional data, consider:
genomic_result <- lassocox(
  data = genomic_data,
  elapsedtime = "survival_months",
  outcome = "death",
  outcomeLevel = "Yes",
  explanatory = c("age", "stage", paste0("GENE_", sprintf("%03d", 1:n_genes))),
  lambda = "lambda.1se",  # Prefer 1-SE rule for high-dimensional data
  nfolds = 5,             # Reduce folds for small samples
  standardize = TRUE      # Essential for genomic data
)
```

### Expected High-Dimensional Results

1. **Variable Selection**: 
   - Out of 502 variables, typically 5-15 selected
   - Selection proportion: 1-3%
   - Identifies sparse prognostic signature

2. **Clinical Interpretation**:
   - Usually includes key clinical variables (age, stage)
   - Selects few high-impact genes
   - Creates interpretable prognostic model

## Example 3: Cardiovascular Risk Prediction

Analyzing cardiovascular risk factors with correlated predictors.

```{r cvd-example}
# Simulate cardiovascular dataset
set.seed(789)
n_subjects <- 200

cvd_data <- data.frame(
  # Outcome
  time_to_event_years = round(rexp(n_subjects, rate = 0.08), 1),
  cv_event = factor(rbinom(n_subjects, 1, 0.3), levels = c(0, 1), 
                    labels = c("No Event", "Event")),
  
  # Demographics
  age = round(rnorm(n_subjects, 62, 15)),
  gender = factor(sample(c("Male", "Female"), n_subjects, replace = TRUE)),
  
  # Clinical measurements (correlated variables)
  bmi = round(rnorm(n_subjects, 28, 6), 1),
  systolic_bp = round(rnorm(n_subjects, 135, 25)),
  diastolic_bp = round(rnorm(n_subjects, 82, 15)),
  total_cholesterol = round(rnorm(n_subjects, 210, 40)),
  hdl_cholesterol = round(rnorm(n_subjects, 45, 12)),
  ldl_cholesterol = round(rnorm(n_subjects, 125, 35)),
  
  # Medical history
  diabetes = factor(sample(c("No", "Yes"), n_subjects, replace = TRUE, prob = c(0.7, 0.3))),
  hypertension = factor(sample(c("No", "Yes"), n_subjects, replace = TRUE, prob = c(0.5, 0.5))),
  smoking = factor(sample(c("Never", "Former", "Current"), n_subjects, replace = TRUE,
                          prob = c(0.5, 0.3, 0.2))),
  
  # Medications
  statin_use = factor(sample(c("No", "Yes"), n_subjects, replace = TRUE, prob = c(0.4, 0.6)))
)

str(cvd_data)
```

### Cardiovascular Analysis

```{r cvd-analysis, eval=FALSE}
cvd_result <- lassocox(
  data = cvd_data,
  elapsedtime = "time_to_event_years",
  outcome = "cv_event",
  outcomeLevel = "Event",
  explanatory = c("age", "gender", "bmi", "systolic_bp", "diastolic_bp",
                  "total_cholesterol", "hdl_cholesterol", "ldl_cholesterol",
                  "diabetes", "hypertension", "smoking", "statin_use"),
  lambda = "lambda.min",  # Use lambda.min for established risk factors
  nfolds = 10
)
```

# Interpreting Results

## Understanding the Output Tables

### 1. Model Summary Table
- **Total Variables**: Number of candidate predictors
- **Selected Variables**: Variables with non-zero coefficients
- **Selection Proportion**: Percentage of variables retained
- **Optimal Lambda**: Selected regularization parameter
- **Sample Size & Events**: Data characteristics

### 2. Coefficients Table
- **Variable**: Selected predictor names
- **Coefficient**: Log hazard ratio (β)
- **Hazard Ratio**: exp(β), interpretable effect size
- **Importance**: Absolute coefficient value (variable importance)

### 3. Performance Table
- **C-index**: Discriminative ability measure
- **Log-rank p-value**: Risk stratification significance
- **Hazard Ratio**: High vs. low risk group comparison

## Clinical Interpretation Guidelines

### Coefficient Interpretation

```{r coef-interpretation, echo=FALSE}
coef_guide <- data.frame(
  `Coefficient Range` = c("< -0.5", "-0.5 to -0.2", "-0.2 to 0.2", "0.2 to 0.5", "> 0.5"),
  `Hazard Ratio` = c("< 0.61", "0.61 - 0.82", "0.82 - 1.22", "1.22 - 1.65", "> 1.65"),
  `Clinical Effect` = c("Strong Protective", "Moderate Protective", "Minimal Effect", 
                       "Moderate Risk", "Strong Risk"),
  `Interpretation` = c("Major risk reduction", "Significant protection", 
                      "Little clinical impact", "Increased risk", "Major risk factor")
)
knitr::kable(coef_guide, caption = "Coefficient Interpretation Guide")
```

### C-index Interpretation

```{r cindex-interpretation, echo=FALSE}
cindex_guide <- data.frame(
  `C-index Range` = c("0.50 - 0.60", "0.60 - 0.70", "0.70 - 0.80", "0.80 - 1.00"),
  `Discrimination` = c("Poor", "Fair", "Good", "Excellent"),
  `Clinical Utility` = c("Not useful", "Limited utility", "Clinically useful", "Highly valuable"),
  `Action` = c("Consider other approaches", "May need improvement", 
              "Suitable for clinical use", "Excellent prognostic tool")
)
knitr::kable(cindex_guide, caption = "C-index Interpretation Guide")
```

## Visualization Interpretation

### 1. Cross-Validation Plot
- **X-axis**: Log lambda values
- **Y-axis**: Cross-validation error
- **Vertical Lines**: 
  - Blue (lambda.min): Minimum CV error
  - Green (lambda.1se): 1-SE rule (more parsimonious)

### 2. Coefficient Plot
- **Red bars**: Risk factors (positive coefficients)
- **Blue bars**: Protective factors (negative coefficients)
- **Bar length**: Coefficient magnitude (effect size)

### 3. Survival Curves
- **Separation**: Better separation indicates stronger risk stratification
- **P-value**: Log-rank test significance
- **Risk tables**: Numbers at risk over time

# Clinical Applications

## 1. Biomarker Discovery

### Genomic Profiling
```{r biomarker-workflow, eval=FALSE}
# Typical biomarker discovery workflow
biomarker_analysis <- lassocox(
  data = genomic_data,
  elapsedtime = "survival_time",
  outcome = "progression",
  outcomeLevel = "Yes",
  explanatory = gene_variables,  # Hundreds of genes
  lambda = "lambda.1se",         # Prefer sparse models
  standardize = TRUE            # Essential for genomic data
)

# Expected outcome: 3-10 key genes selected from hundreds
```

### Clinical Applications:
- **Cancer Prognosis**: Identify prognostic gene signatures
- **Drug Development**: Biomarker-driven patient stratification
- **Personalized Medicine**: Tailored treatment selection

## 2. Clinical Risk Prediction

### Multi-variable Risk Models
```{r risk-model-workflow, eval=FALSE}
# Clinical risk model development
risk_model <- lassocox(
  data = clinical_data,
  elapsedtime = "follow_up_time",
  outcome = "death",
  outcomeLevel = "Yes",
  explanatory = clinical_variables,  # 10-50 clinical factors
  lambda = "lambda.min",            # Retain more clinical variables
  nfolds = 10
)

# Creates parsimonious clinical risk score
```

### Applications:
- **ICU Prognosis**: Predict mortality in critical care
- **Surgical Risk**: Pre-operative risk stratification
- **Chronic Disease**: Long-term outcome prediction

## 3. Treatment Response Prediction

### Precision Medicine
```{r treatment-prediction, eval=FALSE}
# Treatment response prediction
treatment_model <- lassocox(
  data = treatment_data,
  elapsedtime = "time_to_progression",
  outcome = "progression",
  outcomeLevel = "Yes",
  explanatory = c(baseline_factors, biomarkers),
  lambda = "lambda.1se"
)

# Identifies predictors of treatment response
```

# Advanced Topics

## Model Validation

### Cross-Validation Strategy
1. **Internal Validation**: Built-in cross-validation for λ selection
2. **External Validation**: Test on independent dataset
3. **Bootstrap Validation**: Assess model stability
4. **Temporal Validation**: Validate on more recent data

### Validation Metrics
```{r validation-metrics, eval=FALSE}
# Key validation approaches:
# 1. Split-sample validation
train_data <- sample_frac(full_data, 0.7)
test_data <- anti_join(full_data, train_data)

# 2. Time-based validation
early_cohort <- filter(full_data, enrollment_year <= 2015)
recent_cohort <- filter(full_data, enrollment_year > 2015)

# 3. Multi-center validation
center_A <- filter(full_data, center == "A")
other_centers <- filter(full_data, center != "A")
```

## Dealing with Missing Data

### Preprocessing Strategies
1. **Complete Case Analysis**: Default approach
2. **Multiple Imputation**: For missing at random data
3. **Indicator Variables**: For missing not at random
4. **Domain Knowledge**: Clinical expertise for imputation

### Missing Data Patterns
```{r missing-data-handling, eval=FALSE}
# Check missing data patterns
library(VIM)
missing_pattern <- aggr(clinical_data, col = c('navyblue', 'red'), 
                        numbers = TRUE, sortVars = TRUE)

# Handle missing data before Lasso-Cox
# Option 1: Multiple imputation
library(mice)
imputed_data <- mice(clinical_data, m = 5, method = 'pmm')
complete_data <- complete(imputed_data)

# Option 2: Domain-specific imputation
clinical_data$biomarker[is.na(clinical_data$biomarker)] <- median(clinical_data$biomarker, na.rm = TRUE)
```

## Feature Engineering

### Variable Transformation
```{r feature-engineering, eval=FALSE}
# Log transformation for skewed variables
clinical_data$log_biomarker <- log(clinical_data$biomarker + 1)

# Polynomial terms for non-linear effects
clinical_data$age_squared <- clinical_data$age^2

# Interaction terms
clinical_data$age_stage <- clinical_data$age * as.numeric(clinical_data$stage)

# Binning continuous variables
clinical_data$age_group <- cut(clinical_data$age, 
                              breaks = c(0, 50, 65, 80, 100),
                              labels = c("Young", "Middle", "Elderly", "Very Elderly"))
```

# Troubleshooting Common Issues

## 1. No Variables Selected

**Problem**: Lasso selects zero variables (λ too large)

**Solutions**:
```{r no-variables-solution, eval=FALSE}
# Try lambda.min instead of lambda.1se
result <- lassocox(..., lambda = "lambda.min")

# Reduce regularization strength manually
result <- lassocox(..., alpha = 0.5)  # Elastic net (if supported)

# Check for high correlation among predictors
cor_matrix <- cor(predictors, use = "complete.obs")
high_cor <- which(abs(cor_matrix) > 0.9 & cor_matrix != 1, arr.ind = TRUE)
```

## 2. Too Many Variables Selected

**Problem**: Model selects too many variables (underfitting)

**Solutions**:
```{r too-many-variables, eval=FALSE}
# Use lambda.1se for more regularization
result <- lassocox(..., lambda = "lambda.1se")

# Increase number of CV folds
result <- lassocox(..., nfolds = 10)

# Pre-filter variables by univariate significance
univariate_p <- sapply(predictors, function(x) {
  cox_fit <- coxph(Surv(time, event) ~ x)
  summary(cox_fit)$coefficients[, "Pr(>|z|)"]
})
significant_vars <- names(univariate_p)[univariate_p < 0.1]
```

## 3. Poor Model Performance

**Problem**: Low C-index or poor risk stratification

**Solutions**:
```{r poor-performance, eval=FALSE}
# Check data quality
summary(survival_data)
plot(survfit(Surv(time, event) ~ 1))  # Overall survival curve

# Ensure adequate events
table(survival_data$event)  # Need at least 5-10 events per variable

# Consider interaction terms
clinical_data$age_stage_interaction <- clinical_data$age * as.numeric(clinical_data$stage)

# Try different time scales
clinical_data$log_time <- log(clinical_data$time + 1)
```

## 4. Convergence Issues

**Problem**: Algorithm doesn't converge

**Solutions**:
```{r convergence-issues, eval=FALSE}
# Standardize variables
result <- lassocox(..., standardize = TRUE)

# Remove extreme outliers
Q1 <- quantile(continuous_var, 0.25, na.rm = TRUE)
Q3 <- quantile(continuous_var, 0.75, na.rm = TRUE)
IQR <- Q3 - Q1
outliers <- which(continuous_var < (Q1 - 1.5*IQR) | continuous_var > (Q3 + 1.5*IQR))

# Check for perfect separation
table(survival_data$event, survival_data$categorical_predictor)
```

# Best Practices

## Study Design Considerations

### Sample Size Planning
1. **Events per Variable**: Aim for 5-10 events per candidate variable
2. **Total Sample Size**: Consider expected censoring rate
3. **Effect Size**: Larger effects require smaller samples
4. **Multiple Testing**: Account for variable selection process

### Variable Selection
```{r variable-selection-best-practices, eval=FALSE}
# Pre-selection strategies:
# 1. Clinical relevance
clinical_vars <- c("age", "stage", "grade", "treatment")

# 2. Univariate screening (liberal p-value)
univariate_screen <- function(data, time_var, event_var, predictors, p_threshold = 0.2) {
  significant_vars <- c()
  for (var in predictors) {
    formula <- as.formula(paste("Surv(", time_var, ",", event_var, ") ~", var))
    cox_fit <- coxph(formula, data = data)
    p_value <- summary(cox_fit)$coefficients[, "Pr(>|z|)"]
    if (p_value < p_threshold) {
      significant_vars <- c(significant_vars, var)
    }
  }
  return(significant_vars)
}

# 3. Correlation filtering
remove_high_correlation <- function(data, threshold = 0.9) {
  cor_matrix <- cor(data, use = "complete.obs")
  high_cor <- findCorrelation(cor_matrix, cutoff = threshold)
  return(names(data)[-high_cor])
}
```

## Reporting Standards

### Essential Elements for Publication
1. **Methods Section**:
   - Cross-validation procedure (k-folds)
   - Lambda selection method (min vs. 1se)
   - Standardization approach
   - Missing data handling

2. **Results Section**:
   - Number of variables considered and selected
   - Cross-validation performance
   - Final model coefficients and hazard ratios
   - Discrimination metrics (C-index)
   - Risk stratification results

3. **Figures and Tables**:
   - Cross-validation plot
   - Coefficient plot
   - Survival curves by risk groups
   - Model performance summary

### Reproducibility Checklist
```{r reproducibility-checklist, eval=FALSE}
# Reproducibility essentials:
set.seed(123)  # For consistent CV folds

# Document software versions
sessionInfo()

# Save model objects for future use
save(lasso_model, file = "lasso_cox_model.RData")

# Provide clear variable definitions
variable_dictionary <- data.frame(
  Variable = names(clinical_data),
  Description = c("Patient age in years", "Tumor stage", ...),
  Type = c("Continuous", "Categorical", ...),
  Units = c("Years", "I-IV", ...)
)
```

# Conclusion

Lasso-Cox regression is a powerful tool for variable selection in survival analysis, particularly valuable for:

1. **High-dimensional data** where traditional methods fail
2. **Biomarker discovery** in genomic and proteomic studies
3. **Clinical risk modeling** with many potential predictors
4. **Exploratory analysis** to identify key prognostic factors

## Key Takeaways

- **Choose appropriate λ**: lambda.1se for sparsity, lambda.min for performance
- **Validate externally**: Internal CV is not sufficient for clinical use
- **Consider clinical context**: Statistical significance ≠ clinical relevance
- **Report transparently**: Include all analysis decisions and limitations

## Future Directions

- **Elastic Net Extensions**: Combining L1 and L2 penalties
- **Time-varying Effects**: Allowing coefficients to change over time
- **Competing Risks**: Extending to multiple event types
- **Machine Learning Integration**: Combining with other ML approaches

The `lassocox` function in ClinicoPath provides a user-friendly interface for performing these sophisticated analyses, making advanced survival modeling accessible to clinical researchers and biostatisticians.

---

*For more information about ClinicoPath and survival analysis tools, visit the package documentation and tutorials.*
